![Francisco Armero Gutiérrez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francisco Armero Gutiérrez
Investitore di Private Equity presso Clave Mayor SGEIC SA
Posizioni attive di Francisco Armero Gutiérrez
Società | Posizione | Inizio | Fine |
---|---|---|---|
Clave Mayor SGEIC SA
![]() Clave Mayor SGEIC SA Investment ManagersFinance Clave Mayor SGEIC SA (Clave Mayor) is an independent private equity firm founded in 2002. The firm is headquartered in Pamplona with additional offices in Valencia, Spain. | Investitore di Private Equity | 01/05/2012 | - |
Storia della carriera di Francisco Armero Gutiérrez
Precedenti posizioni note di Francisco Armero Gutiérrez
Società | Posizione | Inizio | Fine |
---|---|---|---|
HepaCyl Therapeutics SL
![]() HepaCyl Therapeutics SL BiotechnologyHealth Technology HepaCyl Therapeutics SL is a holding company engaged in the design and development of biomedical products for the detection and treatment of hepatitis and cancer. The company was founded on March 5, 2010 and is headquartered in Valladolid, Spain. | Direttore/Membro del Consiglio | - | 01/02/2016 |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Direttore/Membro del Consiglio | - | - |
Mevion Technology SL
![]() Mevion Technology SL Miscellaneous Commercial ServicesCommercial Services Mevion Technology SL is a holding company engaged in the provision of industrial ionization services, using electron beam accelerators. This technology finds applications in the medical, pharmaceutical, electronics, and aerospace sectors, and allows for product sterilization, sanitation, crosslinking, and depolymerization. It also provides technical consulting, logistics, and microbiological analysis services. The company was founded on September 11, 2009 and is headquartered in Olvega, Spain. | Direttore/Membro del Consiglio | - | - |
Formazione di Francisco Armero Gutiérrez
University of Valladolid | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Universida de Alcalá de Henares | Graduate Degree |
Statistiche
Distribuzione geografica
Spagna | 8 |
Posizioni
Director/Board Member | 3 |
Graduate Degree | 2 |
Private Equity Investor | 1 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Clave Mayor SGEIC SA
![]() Clave Mayor SGEIC SA Investment ManagersFinance Clave Mayor SGEIC SA (Clave Mayor) is an independent private equity firm founded in 2002. The firm is headquartered in Pamplona with additional offices in Valencia, Spain. | Finance |
HepaCyl Therapeutics SL
![]() HepaCyl Therapeutics SL BiotechnologyHealth Technology HepaCyl Therapeutics SL is a holding company engaged in the design and development of biomedical products for the detection and treatment of hepatitis and cancer. The company was founded on March 5, 2010 and is headquartered in Valladolid, Spain. | Health Technology |
Mevion Technology SL
![]() Mevion Technology SL Miscellaneous Commercial ServicesCommercial Services Mevion Technology SL is a holding company engaged in the provision of industrial ionization services, using electron beam accelerators. This technology finds applications in the medical, pharmaceutical, electronics, and aerospace sectors, and allows for product sterilization, sanitation, crosslinking, and depolymerization. It also provides technical consulting, logistics, and microbiological analysis services. The company was founded on September 11, 2009 and is headquartered in Olvega, Spain. | Commercial Services |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |